To develop a ddPCR assay protocol and test its breakpoint detection and sensitivity for breakpoint copy quantification, we turned to the GI-ME-N neuroblastoma cell line, in which a genomic TERT rearrangement was previously reported (3) but not characterized on the level of the DNA sequence. This evidence concerns the gene TERT and neuroblastoma.